Aleafia Health Inc ALEAF

Healthcare Cannabis

Aleafia Health Inc. is a federally licensed Canadian cannabis company offering cannabis products in Canadian adult-use and medical markets and in select international markets. The Company is engaged in the production, sale, and distribution of cannabis. It operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners which provide health and wellness services across Canada. The Company operates two licensed cannabis production facilities and operates a strategically located distribution center all in the province of Ontario, including the largest, outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips and topicals. It markets and sells cannabis products through regulated intermediaries into selected international markets, tactically sells cannabis products into Canadian wholesale markets.

GREY:ALEAF - Post by User

Aleafia Health Inc > ALEAFIA /EMBLEM NEW HC LICENSE

<< Previous

Bullboard Posts

Next >>

Comment by Francoicon Feb 13, 2021 3:12pm

214 Views

Post# 32562483

RE:RE:RE:RE:RE:ALEAFIA /EMBLEM NEW HC LICENSE

Gunner55 wrote: I did. No explanation about resuming. Did they halt? I guess by your post that they did.

Only these messages

Miamirules wrote: https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/industry-licensees-applicants/licensed-cultivators-processors-sellers.html

Francoic wrote:

On the Health Canada site, 2 licenses were granted to Aleafia and 2 to Emblem

- Aleafia farms, 2017-10-13: Cultivation

- Aleafia farms (2nd site), 2020-03-13: Cultivation

- Emblem corp, 2015-08-26: Sale (medical purposes), processing and cultivation

- Emblem corp (2nd site), on 2021-02-12: Sale (medical purposes), processing

Could it be that this license was the one expected for export or EU GMP?

Francoic wrote:

I believe the answer is on the AleafiaHealth/Innovation website :

The Paris processing facility is currently extracting and producing oils, tinctures and gel caps under our adult-use Symbl and medical Emblem brands. This product innovation will scale exponentially with the Paris Phase II expansion, which will add 50,000 kg of extraction capacity annually.

A Phase II expansion features a laboratory being built to GMP standards, which will allow us to sell high-margin products to the German and broader European medical cannabis market.